Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Ping An Donates £1.1m of COVID-19 Medical Supplies to the United Kingdom


News provided by

Ping An Insurance Group Ltd.

03 Apr, 2020, 10:25 GMT

Share this article

Share toX

Share this article

Share toX

HONG KONG and SHANGHAI, April 3, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that Ping An and its Chairman Ma Mingzhe are now responding to the urgent needs of the British government by donating medical supplies to the United Kingdom (U.K.) with a total value of GBP1.1 million (approximately RMB10 million). The donation is an initiative in response to the Extraordinary G20 Leaders' Summit's call to support various nations in fighting the global COVID-19 pandemic.

The donated supplies include medical equipment such as COVID-19 diagnostic test kits, surgical masks, protective clothing, ventilators and safety googles, to help address the serious shortage of medical supplies in the U.K. The donation also includes technological support such as the COVID-19 smart image-reading system developed by Ping An, which can generate rapid and accurate analysis of Computed Tomography (CT) lung scans for each individual case within 15 seconds, with a 97% accuracy rate. This service can aid and support doctors' efficiency and accuracy in diagnosis.

In more detail, Ping An's medical supply donation to the U.K. includes 100,000 surgical masks, 100,000 pairs of gloves, 10,000 safety goggles, 10,000 hand sanitizers, 10,000 face masks, 10,000 COVID-19 diagnostic test kits, 4,000 sets of protective clothing and 15 respirators. The medical technological aid includes 1,000 sets of the COVID-19 smart image-reading system. In China, Ping An's COVID-19 smart image-reading system has supported more than 1,500 medical institutions in China, including Hubei Province, and has assisted doctors with analysis in over one million CT scans for more than 20,000 patients.

As early as 2015, China and the U.K. established a strategic partnership for the 21st century. Both countries have always worked together to help each other. During the fight against the pandemic this year, President Xi Jinping and British Prime Minister Boris Johnson have spoken twice over the phone. The two leaders focused on reaching an agreement on strengthening cooperation in fighting the pandemic and exploring the establishment of a global health partnership. At present, the domestic COVID-19 situation in China is effectively under control, with China in the process of resuming work and production, as its economic and social systems are being restored in an orderly manner. With the current situation in the U.K. being severe and complex, the serious shortage of medical supplies threatens the safety of medical staff and the British people. With this donation, Ping An is supporting Britain's efforts in fighting the outbreak.

"A friend in need is a friend indeed," a Ping An spokesperson said. "Many parts of the world are facing a pandemic, and the situation in the U.K. is serious. The Extraordinary G20 Leaders' Summit has called on the international community to accelerate efforts to contain the outbreak. Since the outbreak of the COVID-19 epidemic in China earlier, countries around the world, including the U.K., have supported China in its fight against the epidemic. Ping An stands ready to fulfill its corporate social responsibility, using its advantages in insurance protection, financial services and healthtech to contribute to the international community's pandemic control efforts. Ping An believes that by working together with the international community, we will triumph over the pandemic."

Last week, Ping An also responded to the needs of the Indonesian government by donating USD1.5 million (RMB 10 million) of COVID-19 medical supplies, including 10,000 sets of safety goggles, 10,000 sets of COVID-19 diagnostic test kits, 150,000 swab kits, 200 infusion pumps, and 100 patient monitors. Medical technology support included 1,000 sets of the COVID-19 smart image-reading system and 10,000 AskBob medical artificial intelligence (AI) assistants. Previously, Ping An Good Doctor cooperated with Grab, the Southeast Asia ride-hailing service provider, to co-launch an online medical service platform, GrabHealth, to provide more than 10,000 daily online consultations.

Since the outbreak of the epidemic in China, Ping An has introduced several initiatives in terms of insurance protection, public welfare donations and medical services. To date, Ping An has donated more than USD20 million (RMB150 million) of supplies and cash. Ping An has also provided free insurance protection for frontline medical staff, journalists, police officers and volunteers. Ping An partnered with the Ming Yuan Charity Fund and has donated RMB18 million (USD2.5 million) to the Chinese Academy of Medical Sciences to support the Phase III clinical trials of COVID-19 drug remdesivir and other clinical trials to combat COVID-19.

Ping An's subsidiary Ping An Good Doctor, an online health platform, has cooperated with 62 provincial, municipal and regional governments to provide real-time online and phone consultations. Since the outbreak, it handled 1.72 billion platform visits. The Ping An Healthcare Testing Center was among the first batch of third-party medical institutions authorized by Hubei Province to carry out the Nucleic Acid Test (NAT), the primary reference for COVID-19 diagnosis. The center has also deployed mobile CT-imaging vehicles to perform 64-slice lung CT scans to screen and diagnose the novel coronavirus-infected pneumonia. The vehicles have conducted over 500 tests daily and over 22,000 tests in total since the end of January.

Ping An Smart Healthcare, the smart health care team of subsidiary Ping An Smart City, created the National Real-time COVID-19 Update System, covering 21 provinces and 31 cities. It provides smart epidemic forecasting for relevant national ministries and commissions as well as 15 provincial health committees, achieving more than 98% accuracy for one-day forecasts and 97% accuracy for seven-day forecasts.

- End -

Related Links

http://www.pingan.cn

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.